UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
———————
FORM 8-K
———————
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 29, 2008
———————
COMPUMED, INC.
(Exact name of registrant as specified in its charter)
———————
DELAWARE | 000-14210 | 95-2860434 |
(State or Other Jurisdiction | (Commission | (I.R.S. Employer |
of Incorporation) | File Number) | Identification No.) |
5777 West Century Blvd., Suite 360, Los Angeles, CA, 90045
(Address of Principal Executive Office) (Zip Code)
(310) 258-5000
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS.
On May 29, 2008, CompuMed, Inc. (“the Company”) announced an agreement with Osteometer MediTech, Inc., a subsidiary of OSI Systems, Inc. (NASDAQ:OSIS), that enables CompuMed to provide a unique suite of affordable and accessible bone densitometry solutions specifically aimed at the point-of-care market.
(d) Exhibits
EXHIBIT NUMBER |
| DESCRIPTION |
| CompuMed Press Release |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
| CompuMed, Inc. | |
|
| (Registrant) | |
|
|
|
|
Date: May 29, 2008 |
| By: | /s/ Maurizio Vecchione |
|
| Name: | Maurizio Vecchione |
|
| Title: | Interim Chief Executive Officer |
|
|
|
|